World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Posters Abstracts
- PDF / 23,087,820 Bytes
- 521 Pages / 595.276 x 790.866 pts Page_size
- 7 Downloads / 170 Views
ABSTRACTS
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Posters Abstracts # International Osteoporosis Foundation and National Osteoporosis Foundation 2019
P101 EFFECT OF ERAS ASSISTED MIPPO IN THE TREATMENT OF PROXIMAL HUMERAL FRACTURE W. Ji1, B. Weiguo1 1 Department of Orthopaedics, The First Affiliated Hospital of Xi’an Jiaotong University, Xian, China Objective: To investigate the effect of ERAS combined with MIPPO in the treatment of proximal humerus fracture. Method: 32 patients with proximal humerus fractures were randomly divided into ERAS combined with MIPPO group and simple MIPPO group that have 16 cases each. These two kinds of groups have same operation, while the treatment before and after operation were very different. The VAS score, the incidence of complications, the average hospitalization days and cost, the time of beginning to walk postoperatively and functional exercise were compared between these two groups. Results: Compared with MIPPO group, the VAS score of ERAS combined with MIPPO group was lower than that of MIPPO group. The incidence of nausea and vomiting was 12.5% vs. 43.75%. The average hospitalization day was 5.7±1.3 d vs. 8.2 ±1.4 d, the average hospitalization cost was 3.1±0.8 w vs. 3.9±0.6 w. The time of beginning to walk postoperatively was 6.2±0.8 h vs. 24.2±2.7 h while the time of beginning functional exercise after operation was 2.1±0.4 d vs. 7.2±1.2 d (P45 y, open contaminated fracture, and patients with head injuries. Results: Total 94 patients (45 single and 49 dual plating) were operated during the study period of 2 y. 38 (77%) patients in a double plating group regained full flexion (135°) and extension (0°) with a good alignment compared to single plating group, seen in 30 (66%) patients at follow-up. Conclusion: Dual plating by 2-incision method resulted in better functional outcome in young patients.
S255
P107 ROLE OF ALENDRONATE/TERIPARATIDE IN STEROID INDUCED OSTEOPOROSIS IN DEVELOPING COUNTRIES A. Q. Qadir1 1 Dow University of Health Sciences, Karachi, Pakistan Objective: Bisphosphonate therapy is the standard of care for the prevention and treatment of steroid-induced osteoporosis. Studies of anabolic therapy in patients who are taking longterm steroids and are at high risk for fracture are lacking. Methods: This is double-blinded randomized controlled trial that was conducted in Civil Hospital Karachi from January 2015 to June 2017. In this study comparison of alendronate with teriparatide in 214 women and men with osteoporosis (ages, 22-65 y) who had received glucocorticoids for at least 3 months (prednisone equivalent, 5 mg daily or more). A total of 107 patients received 20 μg of teriparatide once daily, and 107 received 10 mg of alendronate once daily. The primary result was the change in BMD at the lumbar region. Secondary outcomes included changes in BMD at the total hip and in markers of bone turnover, the time to changes in BMD, the incidence of fractures, and safety. Results: The mean (±SE) BMD at the l
